DE69329982D1 - 4-Carboxyimidazolderivate als Angiotensin-II-Antagonisten und ihre therapeutische Verwendung - Google Patents

4-Carboxyimidazolderivate als Angiotensin-II-Antagonisten und ihre therapeutische Verwendung

Info

Publication number
DE69329982D1
DE69329982D1 DE69329982T DE69329982T DE69329982D1 DE 69329982 D1 DE69329982 D1 DE 69329982D1 DE 69329982 T DE69329982 T DE 69329982T DE 69329982 T DE69329982 T DE 69329982T DE 69329982 D1 DE69329982 D1 DE 69329982D1
Authority
DE
Germany
Prior art keywords
antagonists
carboxyimidazole
angiotensin
derivatives
therapeutic use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69329982T
Other languages
English (en)
Other versions
DE69329982T2 (de
Inventor
Hiroaki Yanagisawa
Yasuo Shimoji
Yoshiya Amomiya
Takuro Kanazaki
Hiroyuki Koike
Toshio Sada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of DE69329982D1 publication Critical patent/DE69329982D1/de
Application granted granted Critical
Publication of DE69329982T2 publication Critical patent/DE69329982T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
DE69329982T 1992-06-02 1993-05-27 4-Carboxyimidazolderivate als Angiotensin-II-Antagonisten und ihre therapeutische Verwendung Expired - Fee Related DE69329982T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14116092 1992-06-02

Publications (2)

Publication Number Publication Date
DE69329982D1 true DE69329982D1 (de) 2001-04-12
DE69329982T2 DE69329982T2 (de) 2001-09-27

Family

ID=15285532

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69329982T Expired - Fee Related DE69329982T2 (de) 1992-06-02 1993-05-27 4-Carboxyimidazolderivate als Angiotensin-II-Antagonisten und ihre therapeutische Verwendung

Country Status (22)

Country Link
EP (1) EP0573218B1 (de)
JP (1) JP3461863B2 (de)
KR (1) KR100300473B1 (de)
CN (1) CN1051766C (de)
AT (1) ATE199548T1 (de)
AU (1) AU661153B2 (de)
CA (1) CA2097444C (de)
CZ (1) CZ287764B6 (de)
DE (1) DE69329982T2 (de)
DK (1) DK0573218T3 (de)
ES (1) ES2155827T3 (de)
FI (1) FI112476B (de)
GR (1) GR3035624T3 (de)
HK (1) HK1011983A1 (de)
HU (1) HUT64329A (de)
IL (1) IL105825A (de)
NO (1) NO303872B1 (de)
NZ (1) NZ247750A (de)
PT (1) PT573218E (de)
RU (1) RU2086541C1 (de)
TW (1) TW228521B (de)
ZA (1) ZA933824B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT398202B (de) * 1991-10-04 1994-10-25 Chem Pharm Forsch Gmbh Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
US5310929A (en) * 1992-08-06 1994-05-10 E. I. Du Pont De Nemours And Company Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
TW259786B (de) * 1992-12-17 1995-10-11 Sankyo Co
WO1995024902A1 (fr) * 1994-03-16 1995-09-21 Sankyo Company, Limited Reducteur de tension oculaire
KR100428725B1 (ko) * 1996-03-30 2004-07-07 주식회사 현대시스콤 디지탈이동통신교환기녹음안내장치의2단계자체루프백시험장치및방법
GR20000100281A (el) * 2000-08-17 2002-05-24 Ιωαννης Ματσουκας Ανταγωνιστες του υποδοχεα της αγγεοτενσινης ιι και συνθετικες μεθοδοι για την θεραπεια της υπερτασης και καρδιοαγγειακων ασθενειων
CN1197866C (zh) * 2003-03-21 2005-04-20 上海医药工业研究院 4，6－二氢呋喃并[3,4－d]咪唑－6－酮衍生物及其盐和制备方法
ES2535291T3 (es) * 2003-04-15 2015-05-08 Daiichi Sankyo Company, Limited Medoxomilo de olmesartán para prevención o tratamiento de enfermedades oculares angiogénicas
CA2555294A1 (en) 2004-02-11 2005-08-25 Marina Yu Etinger Candesartan cilexetil polymorphs
CN101024643A (zh) * 2006-02-20 2007-08-29 上海艾力斯医药科技有限公司 咪唑－5－羧酸类衍生物、制备方法及其应用
TWI448284B (zh) * 2007-04-24 2014-08-11 Theravance Inc 雙效抗高血壓劑
EP2173741B1 (de) * 2007-08-08 2013-10-02 LEK Pharmaceuticals d.d. Verfahren zur herstellung von olmesartan-medoxomil
CN101481374B (zh) * 2008-01-09 2013-01-09 浙江华海药业股份有限公司 1-三苯甲基-5-(1，1｀-联苯基-2基)-1h-四唑类化合物脱去三苯甲基的方法
CN103319461A (zh) * 2013-07-02 2013-09-25 临海天宇药业有限公司 奥美沙坦酯中间体的制备方法以及奥美沙坦酯的合成方法
CN104262332A (zh) * 2014-09-16 2015-01-07 上海信谊百路达药业有限公司 一种奥美沙坦酯的制备方法
CN104356069B (zh) * 2014-11-18 2016-09-14 黄冈鲁班药业有限公司 奥美沙坦酯中间体4-(1-羟基-1-甲基乙基)-2-丙基咪唑-5-羧酸乙酯的制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
HU217958B (hu) * 1989-06-30 2000-05-28 E. I. Du Pont De Nemours And Co. Helyettesített imidazolszármazékok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
IL98319A (en) * 1990-07-05 1997-04-15 Roussel Uclaf Sulphurous derivatives of imidazole, their preparation process, and pharmaceutical compositions containing them
CA2229000C (en) * 1991-02-21 2002-04-09 Sankyo Company, Limited 1-biphenylimidazole derivatives, their preparation and their therapeutic use
EP0505098A1 (de) * 1991-03-19 1992-09-23 Merck & Co. Inc. Imidazolderivate mit funktionelle Säuregruppen als Angiotensin-II-Antagoniste

Also Published As

Publication number Publication date
NO931980D0 (no) 1993-06-01
CN1051766C (zh) 2000-04-26
KR100300473B1 (ko) 2002-01-09
GR3035624T3 (en) 2001-06-29
EP0573218A3 (en) 1994-06-01
FI932492A0 (fi) 1993-06-01
HK1011983A1 (en) 1999-07-23
EP0573218A2 (de) 1993-12-08
NO931980L (no) 1993-12-03
JP3461863B2 (ja) 2003-10-27
AU661153B2 (en) 1995-07-13
JPH0649036A (ja) 1994-02-22
KR940000455A (ko) 1994-01-03
EP0573218B1 (de) 2001-03-07
RU2086541C1 (ru) 1997-08-10
CA2097444A1 (en) 1993-12-03
NO303872B1 (no) 1998-09-14
NZ247750A (en) 1995-05-26
DE69329982T2 (de) 2001-09-27
CN1085896A (zh) 1994-04-27
CZ105093A3 (en) 1993-12-15
TW228521B (de) 1994-08-21
ATE199548T1 (de) 2001-03-15
ES2155827T3 (es) 2001-06-01
DK0573218T3 (da) 2001-06-18
PT573218E (pt) 2001-06-29
ZA933824B (en) 1993-12-27
IL105825A0 (en) 1993-09-22
HUT64329A (en) 1993-12-28
CA2097444C (en) 2005-03-29
IL105825A (en) 1998-01-04
FI932492A (fi) 1993-12-03
FI112476B (fi) 2003-12-15
AU3988093A (en) 1993-12-09
HU9301600D0 (en) 1993-09-28
CZ287764B6 (en) 2001-01-17

Similar Documents

Publication Publication Date Title
ATE199548T1 (de) 4-carboxyimidazolderivate als angiotensin-ii- antagonisten und ihre therapeutische verwendung
HK1073460A1 (en) Substituted 1, 3-oxathiolanes with antiviral properties
ZA944739B (en) Amide and urea derivatives having anti-hypercholesteremic activity their preparation and their therapeutic uses
NO932607D0 (no) Piperidinderivater og anvendelse av disse
ES2057126T3 (es) Metodo de tratamiento de la caquexia y algunos nuevos compuestos para utilizar en este metodo.
FI935693A (fi) Bifenyylin johdannaiset, niiden valmistus ja käyttö korkean verenpaineen ja sydäntautien hoitoon
FI895977A0 (fi) 3,4 -hydroxibenzoyloxipropanolaminfoerlaekemedel.
RU1833381C (en) Method of synthesis of derivatives of 2-methyl-4,5-dihydroxybenzoic acid or their pharmacologically acceptable salts
DE68918240D1 (de) 1,4-Dihydropyridin-Derivate.
MX9705648A (es) Empleo dermatologico de derivados de vitamina d.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee